Addition of suvorexant to ramelteon therapy for improved sleep quality with reduced delirium risk in acute stroke patients

K Kawada, T Ohta, K Tanaka, M Miyamura… - Journal of Stroke and …, 2019 - Elsevier
Abstract Background and Purpose Delirium in acute stroke is associated with poor clinical
outcome. The purpose of this study was to examine the effect of sleep medications on sleep …
被引用次数：39 相关文章

Addition of Suvorexant to Ramelteon Therapy for Improved Sleep Quality with Reduced Delirium Risk in Acute Stroke Patients.

K Kawada, T Ohta, K Tanaka, M Miyamura… - Journal of Stroke and …, 2018 - europepmc.org
Background and purpose Delirium in acute stroke is associated with poor clinical outcome.
The purpose of this study was to examine the effect of sleep medications on sleep quality …

Addition of Suvorexant to Ramelteon Therapy for Improved Sleep Quality with Reduced Delirium Risk in Acute Stroke Patients

K Kawada, T Ohta, K Tanaka… - Journal of Stroke and …, 2019 - strokejournal.org
Abstract Background and Purpose Delirium in acute stroke is associated with poor clinical
outcome. The purpose of this study was to examine the effect of sleep medications on sleep …

[引用][C] Addition of Suvorexant to Ramelteon Therapy for Improved Sleep Quality with Reduced Delirium Risk in Acute Stroke Patients

K Kawada, T Ohta, K Tanaka, M Miyamura… - Journal of Stroke and …, 2019 - cir.nii.ac.jp
Addition of Suvorexant to Ramelteon Therapy for Improved Sleep Quality with Reduced Delirium
Risk in Acute Stroke Patients | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ …

Addition of Suvorexant to Ramelteon Therapy for Improved Sleep Quality with Reduced Delirium Risk in Acute Stroke Patients

K Kawada, T Ohta, K Tanaka… - Journal of stroke …, 2019 - pubmed.ncbi.nlm.nih.gov
Background and purpose Delirium in acute stroke is associated with poor clinical outcome.
The purpose of this study was to examine the effect of sleep medications on sleep quality …